Using recombinant human G-CSF to treat chemotherapy-induced neutropenia over 3 decades: What is next?

• 主要な著者: Jason Xu (著者), Jonathan Sussman (著者), Jessica Xu (著者), Xing Zhao (著者), Xiao Qiang Yan (著者)
• フォーマット: 図書
• 出版事項: Annals of Bone Marrow Research - Peertechz Publications, 2023-09-12.
• 主題: Review Article
• オンライン･アクセス: Connect to this object online.

<p>Chemotherapy-Induced Neutropenia (CIN) is a potentially fatal side effect of cancer treatment, affecting > 50% of cancer patients treated with chemotherapy. Clinical use of recombinant human granulocyte colony-stimulating factor (rhG-CSF) has allowed for primary and secondary prophylaxis...